Lin Yu-ting cleared to return to women’s boxing competition

Olympic champion Lin Yu-ting has been authorised to take part in women’s boxing after World Boxing confirmed she met the organisation’s new eligibility criteria. The 30-year-old Taiwanese pugilist, who won the women’s featherweight title for Chinese Taipei at the 2024 Paris Olympics, had become caught up in a prominent qualification controversy alongside Algeria’s Imane Khelif. Both boxers were formerly banned from the 2023 World Championships by the International Boxing Association, which pointed to non-compliance with female competition requirements. World Boxing, which assumed governance of the sport at Olympic level after the IOC’s removal of the IBA, introduced compulsory sex screening in August 2025. Lin’s approval follows a completed appeal process and health assessment by World Boxing’s independent experts.

The eligibility dispute that stirred up Olympic boxing

Lin Yu-ting’s clearance represents a pivotal moment in one of Olympic sport’s most controversial eligibility disputes. The controversy erupted when the IBA disqualified both Lin and Khelif from the 2023 World Championships, arguing they had failed to meet the criteria for competing in women’s competitions. Despite this setback, Lin proceeded to secure the Olympic gold medal in Paris a few months later, competing under IOC oversight after the regulatory authority revoked the IBA of its recognition due to serious integrity and governance concerns. The episode highlighted significant fractures within the boxing establishment and raised difficult questions about testing for eligibility and fairness in women’s sport.

The controversy heightened the scrutiny surrounding participation criteria in female boxing at the elite echelons of competition. Lin’s withdrawal from numerous competitions after World Boxing’s introduction of compulsory gender testing in August 2025 demonstrated the ambiguity regarding her status. The appeals procedure, even if detailed and finally exonerated the boxer, underscored the personal and occupational strain of extended qualification disputes. World Boxing’s decision to implement objective medical evaluation systems represented an bid to develop clearer, more transparent standards for the sport going forward.

• IBA disqualified Lin and Khelif from 2023 World Championships
• IOC removed IBA over integrity issues and poor governance
• Lin won Olympic gold despite eligibility dispute in Paris
• World Boxing implemented mandatory sex testing in August 2025

World Boxing new testing regime outlined

World Boxing’s compulsory sex screening policy, established in August 2025, constitutes a fundamental shift in how the sport handles eligibility assessment. The updated system centres on a specific genetic test intended to determine biological sex through scientific evaluation, superseding the previous system that had generated widespread controversy. This approach aims to deliver objective criteria that can be measured that World Boxing argues will protect both competitive fairness and athlete safety. The policy covers all competitors in women’s divisions and features a formal appeals procedure, allowing athletes to challenge initial results with accompanying medical documentation. This structure is intended to establish consistency and transparency across international boxing events.

The introduction of compulsory screening has demonstrated importance for athletes like Lin Yu-ting, who experienced prolonged ambiguity whilst the updated protocol was introduced. World Boxing’s decision to include an separate clinical assessment element reflects recognition of the complexity surrounding eligibility determinations. The appeals mechanism allows athletes to submit comprehensive medical documentation for review by World Boxing’s Medical Committee, ensuring that individual circumstances get adequate attention. This equitable method attempts to combine clinical precision with administrative justice, accepting that biological sex lacks simplicity. The body stresses that the policy’s core purpose is preserving fair competition whilst protecting athletes’ rights and dignity throughout the validation process.

How the SRY genetic test operates

The SRY gene test works by identifying the existence of a specific gene that World Boxing designates as an indicator of male biological sex. The test analyses genetic material to ascertain whether the Y chromosome is present, which typically characterises male development. According to World Boxing, this genetic marker provides an scientifically measurable indicator that can guide eligibility decisions. The test reflects a shift to scientific procedures in determining sex determination, departing from previous approaches that were based on different criteria. Results are assessed by impartial clinical experts who examine the findings within broader clinical context.

Athletes who show positive results for the SRY gene are not automatically disqualified; instead, they proceed through an appeal process allowing them to provide further medical evidence. World Boxing’s Medical Review Board reviews all submitted documentation comprehensively before making final eligibility decisions. This appeals mechanism recognises that genetic testing by itself may not capture the complete biological picture, particularly for athletes with conditions impacting sex development. The assessment process considers medical history, hormonal levels, and other relevant clinical factors alongside genetic results. This multi-faceted approach aims to guarantee that decisions are scientifically valid and tailored to individual circumstances rather than determined solely on individual test outcomes.

• Identifies Y chromosome presence indicating male biological sex
• Positive results initiate standalone clinical assessment appeal process
• Clinical Panel examines genetic and clinical data in detail

The appeal procedure and clinical evidence

Following an preliminary assessment in 2025, the Chinese Taipei Boxing Association launched a official challenge on Lin’s behalf, submitting comprehensive medical documentation to World Boxing for impartial examination. The appeal mechanism is a essential protection within World Boxing’s eligibility framework, allowing athletes to challenge initial test results by presenting supporting clinical evidence. This process recognises that sex classification is multifaceted and that genetic markers alone do not provide the complete story of an individual’s medical history and physiology. The CTBA’s decision to pursue the appeal demonstrated confidence in Lin’s case and commitment to exonerating her through proper channels.

The provision of medical documents marked a crucial turning point in the resolution of Lin’s competitive standing. World Boxing’s independent medical experts performed a comprehensive assessment of the evidence provided, taking into account not only genetic test results but also broader clinical context such as hormone levels, clinical background, and additional pertinent physiological data. This thorough methodology guaranteed that the decision was based on full clinical evaluation rather than single test findings. The stringent examination procedure demonstrated World Boxing’s dedication to making decisions that are both scientifically sound and personally suitable, whilst preserving the standards of women’s sport.

What the clinical panel determined

The World Boxing Medical Committee determined that Lin was female from birth and satisfied all requirements for competing in the female category, with no unfair advantage. This decision followed detailed review of the medical documentation and represented a final settlement to the eligibility question that had dominated her career since the 2023 World Championships. The committee’s ruling confirmed Lin’s ability to compete at the top tier of women’s boxing, clearing the path for her comeback in international competition.

What awaits for Lin and women’s boxing

Lin’s clearance marks a pivotal moment not only for her career but for female boxing more broadly. The 30-year-old can now resume competing in World Boxing-sanctioned events after sitting out many events since the compulsory sex testing requirement was established in August 2025. Her return represents a chance to reclaim her status as a two-time world champion and build on her gold medal win from Paris. The resolution also offers resolution for the Chinese Taipei Boxing Association, which has firmly stood behind Lin throughout the contentious eligibility process and celebrated the vindication of her status.

The case has wider significance for how global sporting organisations handle eligibility policies and competitor wellbeing. World Boxing’s choice to establish a thorough appeals mechanism with independent medical review establishes a standard for balancing competitive integrity with personal justice. As Lin prepares to return to the ring, her return to competition will be closely watched by the professional boxing world and further afield, potentially influencing how other sporting bodies develop and refine their own qualification criteria. The way ahead emphasises the significance of thorough, transparent processes that respect both the science of sex determination and the personal respect of athletes.

• Lin can now compete in all World Boxing-sanctioned international competitions without restrictions.
• The appeals procedure showcases World Boxing’s pledge of equitable, fact-based qualification assessments.
• Her return bolsters trust in women’s boxing governance under the new regulatory system.